Abstract Details
|
PRESENTER |
No disclosure on file |
| Julie Van Der Zee | No disclosure on file |
| No disclosure on file | |
| Kristel Sleegers | No disclosure on file |
| Tim Van Langenhove, MD, PhD (UZ Gent) | Dr. Van Langenhove has nothing to disclose. |
| Anne Sieben, MD (Gent University Hospital) | Dr. Sieben has nothing to disclose. |
| Jan L. De Bleecker, MD, PhD, FAAN (Neurology/University Hospital) | Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. |
| Adrian Ivanoiu, MD | No disclosure on file |
| Olivier Deryck | Olivier Deryck has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Olivier Deryck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec, Roche. |
| Patrick Santens | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Peter P. De Deyn, MD, PhD | Dr. De Deyn has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. |
| Patrick Cras, MD, PhD (University of Antwerp) | The institution of Dr. Cras has received research support from Belgian Fund for Scientific Research. Dr. Cras has received personal compensation in the range of $0-$499 for serving as a member with National Bioethics Committee. |
| Rik R. Vandenberghe, MD, PhD | The institution of Dr. Vandenberghe has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. The institution of Dr. Vandenberghe has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Vandenberghe has received research support from Stichting Alzheimer Onderzoek. The institution of Dr. Vandenberghe has received research support from KU Leuven Internal Funds. |
| Jean-Jacques Martin, MD (Universiteit Antwerpen (formerly)) | No disclosure on file |
| No disclosure on file | |
| Sebastiaan Engelborghs, MD, PhD (University of Antwerp, Biomedical Sciences) | No disclosure on file |
| Christine Van Broeckhoven, PhD (University of Antwerp - CDE) | Dr. Van Broeckhoven has nothing to disclose. |